Product portfolio
At Novartis, we reimagine medicine to improve and extend people’s lives. This includes discovering and developing breakthrough therapies, providing quality generics and biosimilars, and finding new ways to deliver these treatments to as many people as possible.
Products are listed alphabetically by brand name. This is not complete medical or product information. Click on the highlighted links next to the product names for complete prescribing information, including important safety information.
If you have a medical condition, promptly see your physician or other healthcare provider.
Showing 69 results
Kymriah® (tisagenlecleucel)
(suspension for intravenous infusion)Leqvio® (inclisiran)
(inclisiran)Locametz® (kit for the preparation of gallium Ga 68 gozetotide injection) (for intravenous use)
(for intravenous use)Lutathera® (lutetium Lu 177 dotatate)
(injection, for intravenous use)Mayzent® (siponimod)
(tablets, for oral use)Mekinist® (trametinib)
(tablets, for oral use)Myfortic® (mycophenolic acid)
(delayed-release tablets, for oral use)Neoral® (cyclosporine capsules, USP)
(soft gelatin capsules)Neoral® (cyclosporine oral solution, USP)
(oral solution)ResourcesNetspot® (kit for the preparation of gallium Ga 68 dotatate injection)
(for intravenous use)Resources
Pagination
- ‹ Previous page
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- › Next page